anticancer/inflammation

BACKGROUND ART An anti-inflammatory agent is a substance that suppresses inflammatory cytokines and/or inflammatory mediators (such as prostaglandins). Aspirin and teprenone are known examples of anti-inflammatory agents. A cancer-preventive agent is a substance that prevents carcinogenesis induced

PRIORITY This application is a National Stage Application based on International PCT Application PCT/KR2016/005529, filed on May 25, 2016, which claims priority to Korean Patent Application No. 10-2015-0073188 filed on May 26, 2015, the disclosures of which are herein incorporated by reference in

FIELD OF THE INVENTION The invention relates to imidazopyridines with anti-cancer activity and more specifically to imidazopyridines which inhibit MEK kinase activity. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian

Throughout this application various publications are referenced. The disclosures of these publications in their entireties are hereby incorporated by reference into this application in order to more fully describe the state of the art to which this invention pertains. FIELD OF THE INVENTION The

BACKGROUND AND FIELD OF THE INVENTION 1. Field of the Invention The present invention deals with defining a phytomedicinal water extract preparation of the plant species Uncaria. In this preparation, many of the ingredients leading to non-specific toxic side effects including palability generated

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention deals with defining a phytomedicinal water extract preparation of the plant species Uncaria. In this preparation, many of the ingredients leading to non-specific toxic side effects including palpability generated from the

BACKGROUND OF THE INVENTION I. Field of the Invention The present application relates to a group of disubstituted and trisubstituted .alpha.-L-xylo-2-hexulofuranoses not previously disclosed, and having anti-inflammatory and anti-proliferative properties to a degree far exceeding those of previously

FIELD OF THE INVENTION The present invention relates to a herbal extract of the plant of Phaleria macrocarpa, and include the extraction method and description of the biological activities of such extract which include antineoplasia, anti-inflammation, and antiangiogenesis. BACKGROUND OF THE

TECHNICAL FIELD The present invention relates to novel compounds which are useful as active ingredients of medicaments such as antitumor agents and anti-inflammatory agents. BACKGROUND ART Most anticancer agents clinically used at present have problems such as appearance of cancer cells with

FIELD OF THE INVENTION The present invention relates to new benzisoselenazolonyl derivatives having antineoplastic, anti-inflammatory and antithrombotic activities as well as their use. Also, the present invention relates to a pharmaceutical composition comprising the benzisoselenazolonyl

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to anti-cancer drug and, more particularly, to synthetic dicinnamate compounds and their analogues that exhibit anti-tumor activity and/or an anti-inflammatory activity, that has beneficial activity principally in

TECHNICAL FIELD The present invention relates to bovine excretion extracts and a process for preparing the same. More specifically, the present invention relates to bovine excretion extracts having not only anticancer activity by potent inhibition of cell proliferation and by anti-oxidation but also

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a therapeutic extract derived from plant biomass for use in regressing cancerous tumors and/or for anti-inflammatory effect and, specifically, to a pharmacologically active compound extracted from the indigenous

FIELD OF INVENTION This invention relates to folic acid antagonists that are metabolically inert exhibiting a high level of anti-inflammatory and anti-tumor activity. Metabolically inert classical antifolates are new and therefore they exhibit unexpected biological properties such as those recited

FIELD OF THE INVENTION This invention relates generally to N-adamant-1-yl-N'-[4-chlorobenzothiazol-2-yl] urea, pharmaceutical compositions comprising the same, and methods of using the same in the treatment of inflammation and as an anticancer radiosensitizing agent. BACKGROUND OF THE INVENTION The